DORZOLAMIDE 2% W/V – Comprehensive Medicine Guide
DORZOLAMIDE 2% W/V is a medication manufactured by SUNVET HEALTHCARE, falling under the category of Uncategorised medicines. It is available in a packaging type of PIECE of 5ML. The actual Maximum Retail Price (MRP) of this medicine is Rs. 380; however, it is currently being offered at a discounted price of Rs. 120, which reflects a discount of 68.42%.
Active Ingredients:
DORZOLAMIDE 2% W/V contains the active ingredient Dorzolamide.
Pharmacological Properties:
Dorzolamide is a carbonic anhydrase inhibitor that works by decreasing the production of aqueous humor in the eye, thereby reducing intraocular pressure. This medication is commonly used to treat glaucoma and ocular hypertension.
Indications:
DORZOLAMIDE 2% W/V is indicated for the treatment of open-angle glaucoma and ocular hypertension. It is used to lower intraocular pressure, thereby reducing the risk of optic nerve damage and vision loss.
Contraindications:
This medication is contraindicated in patients with a known hypersensitivity to dorzolamide or any other components of the formulation. It should be avoided in patients with severe kidney impairment and metabolic acidosis.
Dosage:
The usual recommended dose is one drop in the affected eye(s) three times a day. It is important to follow the dosage regimen prescribed by your healthcare provider. Do not exceed the recommended dosage unless directed by a healthcare professional.
Side Effects:
Common side effects of DORZOLAMIDE 2% W/V may include burning or stinging in the eye, blurred vision, bitter taste, and dry eyes. Contact your doctor if you experience any persistent or severe side effects while using this medication.
Drug Interactions:
Dorzolamide may interact with certain medications, including oral carbonic anhydrase inhibitors, which can increase the risk of side effects. Inform your healthcare provider about all the medications you are currently taking, including prescription, over-the-counter, and herbal products.
Patient Counseling:
Before using DORZOLAMIDE 2% W/V, inform your healthcare provider about any pre-existing medical conditions, allergies, or medications you are taking. Follow the instructions for proper administration of the eye drops. Do not touch the dropper tip to any surface to prevent contamination.
Clinical Evidence:
Clinical studies have shown that DORZOLAMIDE 2% W/V effectively lowers intraocular pressure in patients with open-angle glaucoma and ocular hypertension. Regular monitoring and follow-up with an eye care specialist are essential for the optimal management of these conditions.
Frequently Asked Questions (FAQs):
Q: Can DORZOLAMIDE 2% W/V be used in children?
A: The safety and effectiveness of this medication in pediatric patients have not been established. Consult a healthcare provider for guidance on pediatric use.
Q: How long does it take for DORZOLAMIDE 2% W/V to show its effects?
A: The onset of action of this medication can vary among individuals, but noticeable reductions in intraocular pressure may be observed within a few weeks of starting treatment.
Q: What should I do if I miss a dose of DORZOLAMIDE 2% W/V?
A: If you miss a dose, administer it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and continue with the regular dosing schedule. Do not double the dose to make up for a missed one.
Q: Can DORZOLAMIDE 2% W/V be used during pregnancy?
A: It is advisable to consult with a healthcare provider before using this medication during pregnancy or breastfeeding, as the potential risks and benefits should be carefully evaluated.
Q: Are there any lifestyle modifications recommended while taking DORZOLAMIDE 2% W/V?
A: Maintaining regular follow-up visits with an eye care specialist, adhering to the prescribed dosing schedule, and avoiding activities that may cause eye irritation are important considerations while using this medication.
With its active ingredients, pharmacological properties, indications, contraindications, dosage, side effects, drug interactions, patient counseling, and clinical evidence outlined, DORZOLAMIDE 2% W/V serves as a valuable treatment option for individuals with open-angle glaucoma and ocular hypertension.
